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NEUROSPECIFIC ENOLASE – EARLY DIAGNOSTICAL MARKER OF CNS 
DAMAGE 
Ekuase Philip, Mhando Catherine Samwel- 5th year students 
Scientific supervisor - associate professor Petrashenko V.O. 
Sumy State University, Department of Pediatrics with Medical Genetics 
Mechanisms of hypoxic damage of brain cells are characterized by a complex cascade of 
pathophysiological processes. Final result of this mechanism is the death of neurons due to necrosis 
and apoptosis. In newborn babies is not always possible to objectively assess the condition of the 
CNS defeat, because very often the severity of lesions does not correspond to clinical symptoms, 
especially in premature newborns. So far determination the severity of hypoxic-ischemic CNS lesions 
is still very actually in modern medicine. More objective method of such an assessment is determining 
the activity of neurospecific enolase (NSE). 
Research purpose: to increase the efficiency of diagnosis of hypoxic-ischemic CNS lesions in 
premature infants by determining the activity of NSE in early neonatal period. 
The concentration of NSE was determined in 15 conventionally healthy preterm infants 
(CHPI), which made the comparison group and 64 premature babies with hypoxic-ischemic CNS 
lesions on the 1-7 day of life. They were divided into three groups: I group – 26 premature children 
with mild CNS lesions; II group – 20 premature children with severe hypoxic-ischemic lesions and 
low birth weight; III group – 18 premature newborns with severe damage of central nervous system 
and extremely low birth weight. 
Determining the level of NSE in serum of premature infants found that at the end of the early 
neonatal period in brain cells of children with hypoxic-ischemic CNS lesions showed destructive 
changes of neuronal membranes. About this evidenced significant increase the level of enzyme. So, 
if perinatal CNS lesions of mild degree occur, NSE content in the blood of children of I group 
increased by 45% relative to the comparison group (p <0,05). Thus, even mild hypoxia caused a 
significant alteration of neuronal membranes and damage brain tissue. In the second group of infants 
with low birth weight on the base of severe hypoxia there was further increase activity of this enzyme 
in the blood, which manifested by increased serum concentrations of NSE in 2,2 times relative to the 
children of I group (p <0,001). It should also be noted that its activity in case of severe hypoxia was 
almost 3,3 times higher relative to the comparison group (p <0,001). 
Maximum concentration of enolase reached in premature infants with very low birth weight 
and severe hypoxic-ischemic injury of the CNS. Its contents in serum of premature neonates of III 
group was 4 times greater than in comparison group (p <0,001), increased 2,9 (p <0,001), and 1,3 (p 
<0,05) times relative to infants of I and II groups, respectively. 
Thus, hypoxic-ischemic injury of the nervous tissue causes increased permeability of cell 
membranes and leave into the blood such neurospecific protein as NSE. The high rates of NSE in 
serum of premature infants on a base of hypoxic injury describe breach of the functional condition of 
cell membranes of neurons and correspond to the severity of brain damage due to hypoxia. Therefore, 
to assess the severity of hypoxia is necessary to determine the level of NSE in serum in the early 
neonatal period in premature infants. 
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Properties of inhaled steroids are fundamentally different from the system hormones: they 
work mainly locally on the bronchial mucosa; they are in low quantity getting into the bloodstream 
and minimally affect the whole body. Patients don’t get used to inhaled hormones, on the contrary 
from systemic. More common steroids for inhalation are budesonide, beclomethasone, fluticasone, 
ciclesonide, flunisolide etc. 
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The aim of the work is analyzed literature data about effectiveness of inhaled steroids in 
children with bronchial asthma. 
According to receptor affinity more active fluticasone and ciclesonide (22,0), than budesonide 
(9,4), flunisolide (1,8), and beclomethasone (0,4). 
As for local anti-inflammatory action, first place occupies fluticasone and ciclesonide (1,7), 
than budesonide (1,0), flunisolide (0,7), and beclomethasone (0,4). 
Systemic activity and potential possibility of formation systemic side effects more specific for 
flunisolide (12,8), and beclomethasone (3,5), less typical for budesonide (1,0) and fluticasone (0,07). 
The relative bioavailability is high for budesonide (100%), also for beclomethasone (90%) 
and fluticasone (80-90%), but low for ciclesonide (63%) and flunisolide (21%). 
Clinical efficiency of inhaled steroids was investigated in some trials. At equivalent doses all 
inhaled corticosteroids are equally effective (level of evidence A). 
An improvement in asthma symptoms, exacerbations and side effects of different inhaled 
corticosteroids at equivalent doses could be neither demonstrated nor refuted and the trade-off 
between benefits and harms of using is unclear. The resource use or costs of different ICS should 
therefore also be considered in final decision making. Longer-term superiority trials are needed to 
identify the usefulness and safety of different inhaled corticosteroids. Additionally these studies 
should be powered for patient relevant outcomes (exacerbations, asthma symptoms, quality of life 
and side effects). 
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Group A Streptococcus (GAS), also known as Streptococcus pyogenic, is one of the most 
common pathogenic bacteria in children and causes a broad range of infections and disease states. 
Standard therapy for GAS pharyngitis is penicillin or amoxicillin. Alternative therapy with significant 
penicillin allergy is macrolide antibiotics or possibly clindamycin. Macrolide resistance (MR) in GAS 
remains an increasing worldwide concern. An 11-year-oldpreviously healthy boy presented with 
fever, rash, joint pain, and swelling. His initial complaints were fever, sore throat, ear pain, and rash. 
The patient was reported to have a significant penicillin allergy. After 7 days of illness, he was 
empirically treated with azithromycin and diphenhydramine for 10 days. While still taking 
azithromycin and ∼2 weeks after initial symptoms, he developed fever, ankle pain, and swelling. 
Upon presentation to hospital at 21 days after initial symptom onset, he was afebrile with normal vital 
signs. On examination, he had notable features of a faded, evanescent, erythematous patchy rash on 
upper and lower extremities and splotchy truncal rash. He had pain and swelling of his left ankle, and 
bilateral second to fourth metacarpal phalangeal joints. His leukocyte count was 10.6 G/l , 
hemoglobin 106 g/l, hematocrit 30%, platelet count 409 G/l , erythrocyte sedimentation rate 51 mm/h 
(normal 0–20 mm/h), C-reactive protein 5.8 mg/dL (normal, 0.00–0.8 mg/dL), antistreptolysin O titer 
700 IU/mL (normal 0–200 IU/mL). The results of an echocardiogram, electrocardiogram, and chest 
radiograph were normal. A throat culture revealed an erythromycin-resistant, clindamycin sensitive 
strain of GAS. He was treated with clindamycin and aspirin. He showed prompt resolution of his 
arthritis with resolution of the rash within 2 weeks and no recurrence. The results of a repeat throat 
culture were negative, and he received erythromycin as secondary prophylaxis. 
Group A Streptococcal pharyngitis is a common illness in the pediatric population. Penicillin 
or amoxicillin remain the standard therapy. In nonanaphylactic cases of penicillin allergy, a first-
generation cephalosporin may be used.  
 
 
 
